Chambers Review
Provided by Chambers
Email address
[email protected]Contact number
+41 58 261 5000Share profile
Band 1
Provided by Rolf Watter
Rolf Watter heads the M&A-Transaction practice at Bär & Karrer. He is based in Zurich and Partner since 1994. He has broad experience in all types of M&A transactions, including defence mandates. He also specializes in corporate governance questions and capital market transactions. Rolf Watter is presently chairman of PostFinance AG and a board member of Aryzta AG, AP Alternative Portfolio and of the privately held Faber Castell (Holding) AG. Rolf Watter used to be a board member in a number of Swiss listed companies, namely Ceva Logistics and Nobel Biocare (chairman in both), Zurich Insurance, Syngenta, Centrepulse and Forbo.
Currently board member of AP Alternative Portfolio AG (since 2000) as well as Faber-Castell (Holding) AG (since 1997)
Chairman of PostFinance AG (2013-2021), of Ceva Logistics AG (2018-2019), Nobel Biocare AG (2007-2014, chairman as from 2012) and Chairman of Cablecom Holdings GmbH (2003-2008); board member of Aryzta AG (2016-2020), Zurich Insurance Group (2002-2014), Syngenta (2000-2012), Forbo (1999-2005), Feldschlösschen Getränke AG (2001-2004) and Centerpulse (2002-2003)
Member of the board of directors of Bär & Karrer AG (2007-2009)
Member of the management board of Bär & Karrer (2000-2009)
University of Zurich: Professor of Law (since 1996), Venia Legendi (1990)
Partner of Bär & Karrer (since 1994)
Georgetown University, Washington D.C.: LL.M. (1988)
Admitted to the Zurich Bar (1986)
University of Zurich: Dr. iur. (1985)
University of Zurich: lic. iur. (1983)
Swiss Bar Association (SAV/FSA)
SIX Swiss Exchange: Member of the Admission Board, Recognised Representative for the Listing of Securities
Part-time Professor of Law at the University of Zurich
Co-editor of the law journal "GesKR" and of the Basler Commentaries on Corporate Law, on the Banking Act, the Stock Exchange Act and the Merger Act
He is an editor of the GesKR and the Basler Kommentare on the Code of Obligations II, the Financial Infrastructure Act, the Banking and the Merger Act. He regularly publishes in this fields of work.
German, English, French
Provided by Chambers
Provided by Chambers
For me, his strengths are his experience, commerciality and willingness to make a judgement call. He will tell us exactly what he thinks.
Rolf Watter is one of the best lawyers I have ever had the pleasure to work with.
Rolf Watter is one of the go-to people for transactions in Switzerland. You know you will get all of the experience necessary with him. He is one of the most experienced M&A lawyers in Switzerland.
Rolf Watter just picks up the phone and gets stuff done. He takes ownership and drives the case forward.
For me, his strengths are his experience, commerciality and willingness to make a judgement call. He will tell us exactly what he thinks.
Rolf Watter is one of the best lawyers I have ever had the pleasure to work with.
Rolf Watter is one of the go-to people for transactions in Switzerland. You know you will get all of the experience necessary with him. He is one of the most experienced M&A lawyers in Switzerland.
Rolf Watter just picks up the phone and gets stuff done. He takes ownership and drives the case forward.
4 items provided by Bär & Karrer Ltd
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Firmenich in its Merger with DSM
Bär & Karrer, together with the Dutch law firm Stibbe, acts as legal advisor to Firmenich in its merger with DSM.
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease Vaccine Candidate and Equity Investment
Bär & Karrer Advises Swiss International Air Lines and Edelweiss Air on its CHF 1.5 Billion Credit
Swiss International Air Lines AG and Edelweiss Air AG have entered into a CHF 1.5 billion revolving credit facility agreement with Credit Suisse (Schweiz) AG and UBS Switzerland AG as mandated lead arrangers, coordinators and lenders and additional banks as part of a syndicate.
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Firmenich in its Merger with DSM
Bär & Karrer, together with the Dutch law firm Stibbe, acts as legal advisor to Firmenich in its merger with DSM.
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease Vaccine Candidate and Equity Investment
Bär & Karrer Advises Swiss International Air Lines and Edelweiss Air on its CHF 1.5 Billion Credit
Swiss International Air Lines AG and Edelweiss Air AG have entered into a CHF 1.5 billion revolving credit facility agreement with Credit Suisse (Schweiz) AG and UBS Switzerland AG as mandated lead arrangers, coordinators and lenders and additional banks as part of a syndicate.